Moderna CEO expects emergency use nod for COVID-19 vaccine shortly after FDA's Dec 17 meet
Moderna Inc's COVID-19 vaccine could get emergency use authorization within 24 to 72 hours after U.S. Food and Drug Administration's advisory committee meeting, Chief Executive Officer Stéphane Bancel said on Wednesday.